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SUMMARY
Background: There is good evidence that screening can
detect primary open-angle glaucoma (POAG) in adults
and that early treatment of adults reduces the number
of persons who develop visual field defects or those
whose visual field defects progress.1
Aim: To screen and identify persons with glaucoma among
pensioners in Port Harcourt.
Materials and Method: The study was carried out among
retirees in Rivers State. Verbal consent was obtained
from the Treasury Department of the Rivers State
Ministry of Finance and also from all individuals who
participated in the study.  Demographic data including
age and sex were recorded in the WHO/PBL eye
examination form. Ocular examination consisted of
uncorrected VA measured with Snellen’s chart and then
pin-hole presented when VA < 6/18. Intraocular
pressure was measured with Perkin’s applanation
tonometer. The external eye was examined with a pen
torch and funduscopy with the direct ophthalmoscope.
Glaucoma was diagnosed based on an IOP>21mmHg
and VCDR >0.5 or VCDR = 0.8 with normal intraocular
pressure. 
Results: A total of 176 subjects (351 eyes) were examined;
135(76.7%) male and 41(23.3%) female patients. The
mean age of respondents was 62.33 (±±8.58) years. Of
the 176 subjects examined, 14 had glaucoma (based on
the defined criteria of VCDR > 0.5 and IOP above
21mmHg or VCDR = 0.8 with normal IOP) giving a
relative frequency of 7.95%. Ten subjects had ocular
hypertension. 
Conclusion: There is a need to screen at-risk people for
glaucoma especially the aged. In doing this, sufferers
will be identified early and appropriate treatment
instituted to prevent visual loss.
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INTRODUCTION
Glaucoma is a major cause of visual impairment and
blindness in the world. Available data shows that 5.2 million
individuals are blind from glaucoma and this represents
15% of global blindness.  Of this number, 3 million have1
primary open angle glaucoma (POAG), 2 million, angle
closure glaucoma and 200,000 have congenital glaucoma.1
POAG is the commonest type and has a devastating effect in
black populations. POAG is more likely to result in
irreversible blindness; it appears approximately 10 years
earlier and progresses more rapidly in blacks than in
whites.  Primary open-angle glaucoma is also said to be four2
to five times more common in black populations compared
to Caucasians.  However, there is no difference in rates of3
primary open-angle glaucoma between men and women for
either blacks or whites.  Based on available data, sub-3
Saharan Africa accounts for 19.4% of all cases of POAG,
second only to China with 20.1%. About 13.5 million people
over the age of 40 years are currently being treated for
POAG – this constitutes 60% of global eye patients.  1
For both social and economic reasons, glaucoma
screening is useful and necessary, with possible benefits for
individuals and the health care system arising from the early
diagnosis and early therapy of patients with glaucoma.
Early treatment of patients with glaucoma decreases the
probability that those patients will become blind and lowers
the direct and indirect costs for patients with glaucoma.
Widespread screening is fundamental in limiting the
incidence of glaucoma-associated blindness. 
Both cupping of the optic disc and increased intraocular
pressure have been used to assess  indicators of glaucoma in
a number of screening campaigns in developed countries,
but visual field loss is diagnostically the most specific since
both cupping and intraocular pressure exhibit physiological
variations in any given population.  1
The US Preventive Services Task Force (USPSTF) found
good evidence that screening can detect increased
intraocular pressure (IOP) and early primary open-angle
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glaucoma (POAG) in adults.  The USPSTF also found good 4
evidence that early treatment of adults with increased IOP
detected by screening reduces the number of persons who
develop small, visual field defects, and that the timely
treatment of those with early, asymptomatic POAG
decreases the number of those whose visual field defects
progress.  Similarly, the American Academy of4
Ophthalmology (AAO) recommends screening for glaucoma
as part of a comprehensive adult medical eye evaluation,
starting at the age of 20, and with a frequency depending on 
individual age and other risk factors for glaucoma.  The4
prevalence of primary open-angle glaucoma increases with
increasing age in many populations studied.5
MATERIALS AND METHOD 
Study Setting: The study was carried out among pensioners
in the pension office of the Rivers State Secretariat in Port
Harcourt. Port Harcourt is the capital of Rivers State in the
Niger Delta region of Nigeria. It is the centre of the oil
industry in the country and as such, home to people from
different parts of the country including expatriate workers.
Method: The study was carried out among retirees in Rivers
State who had been invited to the state secretariat to
regularize their banking documents for easy payment of
their monthly allowances. The exercise lasted for about two
weeks, but we were there for three days; and during this
time, almost all who presented for the exercise were
examined. Verbal consent was obtained from the Treasury
Department of the Rivers State Ministry of Finance and also
from all individuals who participated in the study.
Participation was based on oral approval to take part in the
study. Nobody declined inclusion. Demographic data
including age and sex were obtained and recorded in the
WHO/PBL eye examination form. 
Ocular examination started with assessment of both
uncorrected and corrected visual acuity (VA) at 6 metres
using Snellen’s chart. Each eye was tested separately; and
with pin-hole when VA was < 6/18. Intra-ocular pressure
was measured with Perkin’s applanation tonometer (MK-2)
following the instillation of topical tetracaine and flourescein
dye. The external eye was examined with a pen torch and
funduscopy with the direct ophthalmoscope (Welch Allyn
USA REF 11720). Small pupils were dilated with Mydriacyl
0.5% to allow for good funduscopy. All data were recorded
in the WHO/PBL eye examination form. The visual acuities
were done by the medical assistants (ophthalmic nurse and
resident doctor) while all funduscopy and intra-ocular
pressure measurements were carried out by the first and
second author, respectively.
Since the diagnosis of glaucoma is closely associated
with a morphologic change in the optic nerve head, our
screening parameter included assessment of the optic disc in
addition to intraocular pressure measurement. Glaucoma
was diagnosed based on IOP>21mmHg and VCDR >0.5 or
VCDR = 0.8 with normal intraocular pressure. Data was
analyzed using Epinfo version 6.04. Any case of glaucoma
picked up by this process will be referred to the University
of Port Harcourt Teaching Hospital for confirmatory tests
(Slit-lamp examination in conjunction with superfield lenses
and central visual field analysis).
RESULTS 
A total of 176 subjects were examined; 135(76.7%) males and
41(23.3%) females giving a male to female ratio of 3.3:1. All
the subjects were aged between 40 and 89 years with a mean
of 62.33 (±8.58) years. Most subjects (72.7%) were aged
between 50-69 years old while those above 79 years made up
only 3.4% (n=6). The age and sex distribution is shown in
table 1.
Table 1. Age and sex distribution of the study subjects
Age group 
(years)
Male (%) Female (%) Total    (%)
40-49 6 3  9 (5.1%)
50-59 31 15 46 (26.1%)
60-69 66 16 82 (46.6%)
70-79 26 7 33 (18.8%)
80-89 6 - 6 (3.4%)
Total 135 (76.6%) 41 (23.3%) 76 (100%)
A total of 351 eyes of 176 subjects were tested for visual
acuity (one subject had a prosthesis). Of this number, 219
(62.4%) eyes had uncorrected visual acuities (VA) of 6/6-
6/18, and 93 eyes (26.5%); visual acuities of 6/24-6/60. Only
two eyes had visual acuities of no perception of light (NPL).
See table 2.
Intraocular pressure (IOP) was measured in 351 eyes
and the mean was 17.97 (±4.61) mmHg. The mean IOP for
the right eye was 17.45 (±4.15) mmHg and 18.50 (±4.98)
mmHg for the left eye. Most subjects (91.2%) had IOPs of
between 10-21mmHg. Only 8.6% of the subjects had IOPs 22
mmHg or higher (table 3). There was no statistically
significant difference between the mean IOP in the right and
left eyes (X = 0.032, Student t-test=2.147).2
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 Table 2. Presenting uncorrected  visual acuity (VA) in both
  eyes
VA Right Eye (%) Left Eye (%) Total (%)
6/6-6/9    64 (36.4%)   61(34.9%) 125 (35.6%)
6/12-6/18    44 (25%)   50 (28.6%)   94 (26.8%)
6/24-6/60    52 (29.5%)   41(23.4%)   93 (26.5%)
CF-LP    16 (9.1%)   21 (12%)   37 (10.5%)
NPL   Nil     2(1.1%) 2 (0.6%)
Total 176 175 351 (100%)
CF = counting fingers ; LP= light perception 
NPL = no perception of light








< 10   1 (0.5%) Nil (%)     1 (0.2%)
40830 69 (39.3%)  53 (%) 122 (34.8%)
16-21 95 (54%) 103 (%) 198 (56.4%)
22-27   7 (4%)   10 (%)   17 (4.8%)
28-39   2 (1.1%)     7 (%)     9 (2.6%)
40 and above   2 (1.1%)     2 (%)     4 (1.2%)
Total 176 175 351(100%)
Mean IOP RE = 17.448 ±4.150 mmHg  
Mean IOP LE = 18.498 ±4.984 mmHg   
Mean IOP Both eyes = 17.973 ±4.609
Funduscopy was done in 304 (86.6%) eyes (151 RE; 153
LE). The remaining eyes (n = 47) had cataracts so the fundus
could not be assessed. The mean VCDR for both eyes was
0.417 (±0.181). In over 80% of the eyes, the vertical cup/disc
ratio (VCDR) was between 0.1- 0.5. The rest (18.7%) had
VCDRs of 0.6-0.9. There was no eye with a VCDR of 1.0. The
mean VCDR for the right eye was 0.42 (±±0.181) and 0.414
(±0.182) for the left eye. There was no statistically significant
difference between the VCDR of the right and left eyes (P-
value = 0.773). 









0.1-0.5 123 (81.5%) 124 (81.1%) 247 (81.3%)
0.6-0.9 28 (18.5%) 29 (18.9%) 57 (18.7%)
>0.9 Nil Nil
Total 151 153 304 (100%)
Mean VCDR RE= 0.42 ±0.181;       Mean VCDR LE =0.414 ±0.182;
Mean VCDR Both Eyes =0.417 ±0.181
Of the 176 subjects screened, 14 had glaucoma (based on
the defined criteria of VCDR > 0.5 and IOP > 21mmHg; or
VCDR = 0.8 with normal IOP). The 14 glaucoma cases
included five subjects with normal IOP and nine with
elevated IOP. This gives a relative frequency of  7.95%.
There were 12 males and two females and almost all were
aged between 60 and 75 years old. Ten subjects had ocular
hypertension (IOP above 22mmHg in both eyes with no
cupping of the optic disc).
DISCUSSION
Intraocular pressure > 22 mmHg and the optic disc
assessment as screening parameters have been found to have
good specificity (> 95%) in some studies though there was
relatively poor sensitivity (< 75%).  Screening could be used6 
as a filter to identify eyes that have higher risk of glaucoma,
and in one study the prevalence of glaucoma was found to
be 4.75%.  Definite cases of glaucoma have also been6  
identified by some screening studies and in a study
involving those 30 years and older, the prevalence of
glaucoma was 2.10%.  This study has a much higher relative7
frequency of glaucoma (7.95%) compared to the other
studies probably because our study targetted a specific
group of people (pensioners) and older age is a known risk
factor to glaucoma. Also, the first study involved a younger
population (30 years and above) while the second was
population-based, cross-sectional and involved a larger
number of people which could explain the lower prevalence
obtained in those studies. Some studies have also noted that
treatment of patients with increased IOP reduces the 
development of visual field defects by more than 40%  and 8
that screening sometimes extends life and/or improves the 
quality of life.9 
Though primary open glaucoma is known to be
commoner in blacks and to have a more devastating effect
in them,  as half of those with POAG may not be aware that10
they have the disease,  hence the importance of this study.3,11
Glaucoma screening is part of the recommendation of the
American Academy of Ophthalmology as part of a
comprehensive adult medical eye evaluation, starting at the
age of 20, and that the frequency should depend on an
individual's age and other risk factors for glaucoma.  Even4
though the utility of tonometry as a screening tool for POAG
is limited (because IOP fluctuates over time and diurnally,
and therefore more than one reading may be needed to
detect elevated IOP), some studies have found it to have a
specificity of between 92-95%.   6,15,16 
The findings from our study corresponds with other
studies where it was found that men are more affected than
women.  In our study, however, the males tested were six12
times as affected as females tested, but this may be because
of a larger male representation in the survey. About 36% of
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our glaucoma cases had normal intraocular pressure and
this is similar to findings in other studies.  11,13,14
Despite this high relative frequency of glaucoma in our
study, some cases of glaucoma may have been missed
because the central visual fields were not analyzed and also,
the variability in the time IOP was measured may not give
the correct picture of the subject’s intra-ocular pressure.
CONCLUSION
Screening is important in the detection of glaucoma but
should be done in two phases. In the first phase, simple and
portable tools can be used to identify cases of suspected
glaucoma and in the second phase, glaucoma suspects can
then be reviewed in detail in a referral centre with facilities
for at least central visual field analysis and fundus
photography, before commencement of glaucoma treatment.
The cases we identified as glaucoma were all referred to the
University of Port Harcourt Teaching Hospital for slit-lamp
examination and central visual field analysis. 
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